SPP1 and autoimmune disease: The detrimental activity of OPN in autoimmune diseases may involve its ability to promote secretion of IL-17 and IFN-γ in T cells and IL-6 in monocytes, to promote lymphocyte adhesion and migration, to inhibit activation-induced cell death that is involved in the switching off the immune response and to support TFH differentiation (Figure 2).